UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000031394 |
|---|---|
| Receipt number | R000035825 |
| Scientific Title | early response to Combination Action oN Active Reaction to Incetin agent and SGLT2i |
| Date of disclosure of the study information | 2018/02/20 |
| Last modified on | 2018/02/20 19:09:05 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
early response to Combination Action oN Active Reaction to Incetin agent and SGLT2i
Acronym
CANARIS
Scientific Title
early response to Combination Action oN Active Reaction to Incetin agent and SGLT2i
Scientific Title:Acronym
CANARIS
Region
| Japan |
Condition
Condition
type 2 daibetes mellitus
Classification by specialty
| Medicine in general |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Efficacy including hormone and metabolic system using dietary load test
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Blood glucose level, insulin level, glucagon level, FFA
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Self control
Stratification
NO
Dynamic allocation
NO
Institution consideration
Institution is not considered as adjustment factor.
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Medicine |
Interventions/Control_1
Before administration of SGLT2 inhibitor, after administration
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 75 | years-old | > |
Gender
Male and Female
Key inclusion criteria
In hospitalized type 2 diabetic patients who are not receiving SGLT-2 inhibitor and incretin agonist (DPP 4 inhibitor, GLP-1 inhibitor)
Key exclusion criteria
Patients with a history of hypersensitivity to the study drug
Patients with severe ketosis, diabetic coma or precoma, type 1 diabetes
Patients with severe infections, before and after surgery, serious trauma
Pregnant or lactating women and pregnant women
Patients who the doctor judged unsuitable for research participation
Explain participation of this research, patients who can not obtain consent
Target sample size
30
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | OKAHATA SUMIE |
Organization
Toho University Ohashi Medical Center
Division name
Division of Diabetes and Metabolism
Zip code
Address
2-17-6, Ohashi Meguro-ku, Tokyo
TEL
03-3468-1251
sokahata-tky@umin.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | OKAHATA SUMIE |
Organization
Toho University Ohashi Medical Center
Division name
Division of Diabetes and Metabolism
Zip code
Address
2-17-6, Ohashi Meguro-ku, Tokyo
TEL
03-3468-1251
Homepage URL
sokahata-tky@umin.ac.jp
Sponsor or person
Institute
Toho University Ohashi Medical Center
Institute
Department
Personal name
Funding Source
Organization
non
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2018 | Year | 02 | Month | 20 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Enrolling by invitation
Date of protocol fixation
| 2015 | Year | 02 | Month | 20 | Day |
Date of IRB
Anticipated trial start date
| 2015 | Year | 03 | Month | 09 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2018 | Year | 02 | Month | 20 | Day |
Last modified on
| 2018 | Year | 02 | Month | 20 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035825
